Overview

Study of Gemcitabine, Irinotecan and Panitumumab in Patients With Advanced and Metastatic Biliary Tract Adenocarcinoma

Status:
Completed
Trial end date:
2014-09-26
Target enrollment:
Participant gender:
Summary
This study evaluates the combination chemotherapy with gemcitabine, irinotecan and panitumumab in patients with advanced biliary cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Abramson Cancer Center of the University of Pennsylvania
Treatments:
Antibodies, Monoclonal
Camptothecin
Gemcitabine
Irinotecan
Panitumumab